Close Menu

NEW YORK (GenomeWeb) – Genomic Health reported after the close of the market Tuesday that its fourth quarter revenues rose 10 percent year over year, buoyed by an increase in its prostate cancer testing business and international test revenues.

For the three months ended Dec. 31, 2016, Genomic Health's total revenues rose to $82.7 million from $75.1 million in the same period last year. Wall street analysts had expected, on average, revenue of $84.1 million.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.